A subsidiary of UnitedHealth Group Inc. has acquired ChinaGate, a firm that helps drug, device and biotech companies enter the Chinese market, the companies said Wednesday.
I3, a company owned by Minnetonka-based UnitedHealth's technology arm, Ingenix, bought Shanghai-based ChinaGate for an undisclosed sum.
The companies said ChinaGate has extensive experience with the State Food and Drug Administration, China's version of the U.S. Food and Drug Administration, and has helped bring more than 450 medical and consumer health products into the Chinese market.
ChinaGate has also helped clients sell Chinese-made products globally.
CHEN MAY YEE
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
Forget the 1970s, 'stagflation' playbook may be found in 2005
Many of the economic conditions we're now experiencing were happening in 2005.
Business
Read aloud your writing to catch mistakes
You will also discern if it is clear and precise — and says what you mean.
Business
Financial scams bloom on social media sites
Consumers should double-check if it looks like a friend or relative is asking for money via social media.
Business
Shopping for Medicare plans invites headaches but can spell savings for Minnesotans
Many seniors will find flat or lower premiums for 2022 but some drug coverage is getting more expensive and plans will disappear in a few counties.
Business
Apartments at Northrup King complex will house artists in northeast Minneapolis
Artspace will convert two vacant industrial buildings into 84 affordable artist apartments and a cultural center.
